Consensus ESG Ratings
Member Sign In
ESG News For VGP N.V.
These sites contributed news to this page:
-
Colossal Accelerates Research and Development of Life-Saving Vaccine to Prevent Elephant Extinction
The de-extinction company doubles down on genomic sequencing of EEHV for the development of a vaccine that can eradicate one of the deadliest viruses affecting the endangered elephant -
Colossal Biosciences and the Vertebrate Genomes Project Will Preserve the Genetic Code of all Endangered Elephant Species Through Genomic Sequencing
For the first time, all three living elephant species – Asian Elephant, African Elephant and Forest Elephant – will be genetically rescued in landmark species de-extinction effort